Private equity firm increases stake in Nottingham life sciences company
Private equity firm Mercia Technologies has invested a further £2m into Nottingham-based life sciences firm Locate Bio.
Locate has received £1.8m of direct investment from Mercia, with the balance coming from the Midlands Engine Investment Fund, which the Group manages on behalf of the British Business Bank. Mercia's direct equity stake is now 21.6%.
Locate is a gene and cell therapy company developing a pipeline of next generation medicines which utilise its proprietary technologies for non-viral gene therapy and cell therapy... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...